SLC9A1 and breast cancer: Further, p-ezrin enhances NHE1 activity at invadopodia, invadopodial-dependent ECM proteolysis and cell invasion, thus inducing an invasive phenotype in breast cancer cells in vitro by coordinating an ECM proteolytic/invasion signal module.